liver cancer

"In the small hepatocellular carcinoma after tumor surgery very low load this particular stage, the use of Chinese medicine relatively low toxicity and mechanism of the role of a more comprehensive treatment, prevention of recurrence of the effect may be more advantages." Created "antidote to" a HCC series of comprehensive treatment programme Second Military Medical University, Professor Ling Changquan chairman of the Department of Traditional Chinese Medicine, the enactment of the Chinese Medicine small hepatocellular carcinoma ways to reduce the relapse rate after surgery, showing full confidence.

Be included in the "11th Five-Year" plan of the national scientific and technological support "preventive medicine integrated programme of small hepatocellular carcinoma recurrence" issue, the Second Military Medical University, recently subsidiary Changhai Hospital activated. This reporter learned that, the project will select a total of 360 accepted the radical surgery in patients with small hepatocellular carcinoma (ie, a single tumor less than 5 cm in diameter, or in the same half of the liver tumor diameter of two and less than 5 cm), random Packet transcatheter arterial chemoembolization for preventive treatment, or "anti-tumor medicine intravenous fluids + medicine decoction" treatment, the ultimate test of Chinese medicine in the integrated programme delay tumor recurrence time and reduce the relapse rate of the role of advantages.

LING Chang led by Professor Chang-Hai Hospital of Traditional Chinese Medicine Branch, since the start 10 years ago for small liver cancer relapse prevention in Chinese medicine research. The use of traditional Chinese medicines which the toad skin made of dried whole cinobufacini injection, in combination with the Differential Treatment of Poncirus Erchen Tang Chai, Chidan pink soup, gardenia Qin bitter summer soup, PEC sand Fu Chak soup different decoction The programme, the treated 3,000 cases of the patients recalled statistics, and that "preventive intervention" than can reduce the recurrence rate of 5-10 percentage points.

Participate in the large-scale prospective study of the city and also the Waibu many hospitals, and experts expect several years of hard work, a real reliable clinical data for patients with small hepatocellular carcinoma recurrence prevention with Chinese characteristics provides the scientific effective integrated programmes.